ModivCare Inc. (MODV)
USD 1.29
(13.16%)
USD 1.29
(13.16%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -204.46 Million USD | -10999.89% |
| 2022 | -1.84 Million USD | -105.76% |
| 2021 | 31.96 Million USD | -64.02% |
| 2020 | 88.83 Million USD | 1893.58% |
| 2019 | -4.95 Million USD | 73.91% |
| 2018 | -18.98 Million USD | -135.57% |
| 2017 | 53.36 Million USD | -41.94% |
| 2016 | 91.92 Million USD | 9.84% |
| 2015 | 83.69 Million USD | 312.8% |
| 2014 | 20.27 Million USD | 4.31% |
| 2013 | 19.43 Million USD | 129.17% |
| 2012 | 8.48 Million USD | -49.93% |
| 2011 | 16.94 Million USD | -28.3% |
| 2010 | 23.62 Million USD | 11.84% |
| 2009 | 21.12 Million USD | 113.58% |
| 2008 | -155.6 Million USD | -1181.44% |
| 2007 | 14.38 Million USD | 53.38% |
| 2006 | 9.38 Million USD | -0.47% |
| 2005 | 9.42 Million USD | 33.03% |
| 2004 | 7.08 Million USD | 167.75% |
| 2003 | 2.64 Million USD | 156.07% |
| 2002 | -4.71 Million USD | 85.16% |
| 2001 | -31.8 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -22.3 Million USD | -324.6% |
| 2024 Q2 | -128.88 Million USD | -477.96% |
| 2023 Q3 | -4.3 Million USD | 97.75% |
| 2023 Q4 | -5.25 Million USD | -22.08% |
| 2023 FY | -204.46 Million USD | -10999.89% |
| 2023 Q1 | -5.98 Million USD | -19.67% |
| 2023 Q2 | -190.94 Million USD | -3089.31% |
| 2022 Q3 | -2.05 Million USD | -138.21% |
| 2022 Q4 | -5 Million USD | -143.22% |
| 2022 FY | -1.84 Million USD | -105.76% |
| 2022 Q2 | 5.38 Million USD | 3362.42% |
| 2022 Q1 | -165 Thousand USD | 99.48% |
| 2021 Q3 | -7.57 Million USD | -155.37% |
| 2021 Q1 | 18.84 Million USD | 714.68% |
| 2021 FY | 31.96 Million USD | -64.02% |
| 2021 Q2 | 13.67 Million USD | -27.43% |
| 2021 Q4 | -31.52 Million USD | -316.5% |
| 2020 FY | 88.83 Million USD | 1893.58% |
| 2020 Q1 | 12.99 Million USD | 314.56% |
| 2020 Q2 | 36.99 Million USD | 184.64% |
| 2020 Q3 | 35.34 Million USD | -4.47% |
| 2020 Q4 | -3.06 Million USD | -108.67% |
| 2019 Q3 | 8.15 Million USD | 390.18% |
| 2019 FY | -4.95 Million USD | 73.91% |
| 2019 Q1 | 582 Thousand USD | 102.86% |
| 2019 Q2 | -2.81 Million USD | -582.82% |
| 2019 Q4 | -6.05 Million USD | -174.29% |
| 2018 Q2 | -11.21 Million USD | -306.54% |
| 2018 Q4 | -20.35 Million USD | -384.46% |
| 2018 FY | -18.98 Million USD | -135.57% |
| 2018 Q1 | 5.43 Million USD | -83.51% |
| 2018 Q3 | 7.15 Million USD | 163.79% |
| 2017 Q2 | 3.91 Million USD | 190.52% |
| 2017 FY | 53.36 Million USD | -41.94% |
| 2017 Q4 | 32.93 Million USD | 175.36% |
| 2017 Q3 | 11.96 Million USD | 205.54% |
| 2017 Q1 | -4.32 Million USD | -106.12% |
| 2016 FY | 91.92 Million USD | 9.84% |
| 2016 Q4 | 70.67 Million USD | 10773.38% |
| 2016 Q3 | 650 Thousand USD | -85.94% |
| 2016 Q2 | 4.62 Million USD | 106.85% |
| 2016 Q1 | 2.23 Million USD | -96.59% |
| 2015 Q3 | -5.57 Million USD | -183.98% |
| 2015 Q2 | 6.63 Million USD | 30.28% |
| 2015 Q1 | 5.09 Million USD | -27.78% |
| 2015 FY | 83.69 Million USD | 312.8% |
| 2015 Q4 | 65.5 Million USD | 1275.88% |
| 2014 Q1 | 6.28 Million USD | 87.28% |
| 2014 Q2 | 6.67 Million USD | 6.12% |
| 2014 Q3 | 266 Thousand USD | -96.01% |
| 2014 Q4 | 7.05 Million USD | 2550.75% |
| 2014 FY | 20.27 Million USD | 4.31% |
| 2013 Q3 | 3.52 Million USD | -39.98% |
| 2013 Q2 | 5.87 Million USD | -12.01% |
| 2013 FY | 19.43 Million USD | 129.17% |
| 2013 Q4 | 3.35 Million USD | -4.82% |
| 2013 Q1 | 6.67 Million USD | 133.09% |
| 2012 Q3 | 1.15 Million USD | -18.34% |
| 2012 Q4 | 2.86 Million USD | 147.4% |
| 2012 FY | 8.48 Million USD | -49.93% |
| 2012 Q1 | 3.04 Million USD | -46.3% |
| 2012 Q2 | 1.41 Million USD | -53.39% |
| 2011 Q3 | 1.95 Million USD | -59.81% |
| 2011 Q1 | 4.46 Million USD | 3.09% |
| 2011 Q2 | 4.85 Million USD | 8.63% |
| 2011 Q4 | 5.66 Million USD | 190.37% |
| 2011 FY | 16.94 Million USD | -28.3% |
| 2010 Q4 | 4.33 Million USD | 49.1% |
| 2010 Q2 | 7.27 Million USD | -20.1% |
| 2010 Q3 | 2.9 Million USD | -60.04% |
| 2010 Q1 | 9.1 Million USD | 64.07% |
| 2010 FY | 23.62 Million USD | 11.84% |
| 2009 FY | 21.12 Million USD | 113.58% |
| 2009 Q1 | 5.87 Million USD | 126.77% |
| 2009 Q4 | 5.55 Million USD | 24.79% |
| 2009 Q3 | 4.44 Million USD | -15.28% |
| 2009 Q2 | 5.25 Million USD | -10.66% |
| 2008 FY | -155.6 Million USD | -1181.44% |
| 2008 Q4 | -21.95 Million USD | 84.41% |
| 2008 Q3 | -140.79 Million USD | -4195.24% |
| 2008 Q2 | 3.43 Million USD | -7.18% |
| 2008 Q1 | 3.7 Million USD | -13.76% |
| 2007 Q1 | 3.31 Million USD | 396.16% |
| 2007 Q2 | 3.57 Million USD | 7.76% |
| 2007 FY | 14.38 Million USD | 53.38% |
| 2007 Q3 | 3.19 Million USD | -10.58% |
| 2007 Q4 | 4.29 Million USD | 34.29% |
| 2006 Q2 | 3.33 Million USD | 27.08% |
| 2006 Q1 | 2.62 Million USD | 10.77% |
| 2006 Q4 | 668.91 Thousand USD | -75.66% |
| 2006 FY | 9.38 Million USD | -0.47% |
| 2006 Q3 | 2.74 Million USD | -17.68% |
| 2005 Q1 | 2.09 Million USD | -13.33% |
| 2005 Q2 | 2.37 Million USD | 13.53% |
| 2005 Q3 | 2.58 Million USD | 8.61% |
| 2005 Q4 | 2.37 Million USD | -8.17% |
| 2005 FY | 9.42 Million USD | 33.03% |
| 2004 Q2 | 1.45 Million USD | 32.43% |
| 2004 FY | 7.08 Million USD | 167.75% |
| 2004 Q1 | 1.1 Million USD | -3.44% |
| 2004 Q4 | 2.41 Million USD | 14.66% |
| 2004 Q3 | 2.1 Million USD | 44.41% |
| 2003 Q4 | 1.14 Million USD | 581.95% |
| 2003 FY | 2.64 Million USD | 156.07% |
| 2003 Q3 | 167.35 Thousand USD | -74.46% |
| 2003 Q2 | 655.36 Thousand USD | 120.39% |
| 2003 Q1 | 297.36 Thousand USD | 0.0% |
| 2002 FY | -4.71 Million USD | 85.16% |
| 2001 Q3 | -7.57 Million USD | -155.37% |
| 2001 Q4 | -31.52 Million USD | -316.45% |
| 2001 FY | -31.8 Million USD | 0.0% |
| 2001 Q2 | 13.67 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | -21.66 Million USD | -843.647% |
| Addus HomeCare Corporation | 62.51 Million USD | 427.052% |
| AirSculpt Technologies, Inc. | -4.47 Million USD | -4464.858% |
| Amedisys, Inc. | -9.74 Million USD | -1997.671% |
| American Oncology Network, Inc. | -5.54 Million USD | -3589.282% |
| Astrana Health, Inc. | 60.71 Million USD | 436.743% |
| Aveanna Healthcare Holdings Inc. | -134.52 Million USD | -51.988% |
| IMAC Holdings, Inc. | - USD | Infinity% |
| biote Corp. | 3.31 Million USD | 6265.862% |
| Cryo-Cell International, Inc. | -9.52 Million USD | -2047.313% |
| Cross Country Healthcare, Inc. | 72.63 Million USD | 381.505% |
| COMPASS Pathways plc | -118.46 Million USD | -72.593% |
| DocGo Inc. | 6.85 Million USD | 3081.138% |
| The Ensign Group, Inc. | 209.39 Million USD | 197.641% |
| Healthcare Services Group, Inc. | 38.38 Million USD | 632.642% |
| InnovAge Holding Corp. | -21.33 Million USD | -858.197% |
| Assure Holdings Corp. | -26.07 Million USD | -684.033% |
| The Joint Corp. | -9.75 Million USD | -1996.553% |
| LifeStance Health Group, Inc. | -186.26 Million USD | -9.77% |
| Mobile-health Network Solutions Class A Ordinary Shares | -15.6 Million USD | -1210.406% |
| NewGenIvf Group Limited | 130.19 Thousand USD | 157143.773% |
| Novo Integrated Sciences, Inc. | -13.21 Million USD | -1447.234% |
| Option Care Health, Inc. | 267.09 Million USD | 176.551% |
| P3 Health Partners Inc. | -57.77 Million USD | -253.902% |
| P3 Health Partners Inc. | -57.77 Million USD | -253.902% |
| The Pennant Group, Inc. | 13.37 Million USD | 1628.216% |
| Surgery Partners, Inc. | -11.9 Million USD | -1618.151% |
| Syra Health Corp. Class A Common Stock | -2.93 Million USD | -6858.344% |
| Talkspace, Inc. | -19.18 Million USD | -965.895% |
| Talkspace, Inc. | -19.18 Million USD | -965.895% |
| The Oncology Institute, Inc. | -83.06 Million USD | -146.136% |
| The Oncology Institute, Inc. | -83.06 Million USD | -146.136% |